Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science, [2004]-

Depression*/therapy ; Internet-Based Intervention* ; Refugees*/psychology; COVID-19/epidemiology ; Humans ; Lebanon/epidemiology ; Pandemics ; Single-Blind Method ; Syria/ethnology ; Treatment Outcome ; World Health Organization

Background: Most displaced people with mental disorders in low- and middle-income countries do not receive effective care, and their access to care has deteriorated during the Coronavirus Disease 2019 (COVID-19) pandemic. Digital mental health interventions are scalable when digital access is adequate, and they can be safely delivered during the COVID-19 pandemic. We examined whether a new WHO-guided digital mental health intervention, Step-by-Step, in which participants were supported by a nonspecialist helper, was effective in reducing depression among displaced people in Lebanon.
Methods and Findings: We conducted a single-blind, 2-arm pragmatic randomized clinical trial, comparing guided Step-by-Step with enhanced care as usual (ECAU) among displaced Syrians suffering from depression and impaired functioning in Lebanon. Primary outcomes were depression (Patient Health Questionnaire, PHQ-9) and impaired functioning (WHO Disability Assessment Schedule-12, WHODAS) at posttreatment. Secondary outcomes included subjective well-being, anxiety, post-traumatic stress, and self-described problems. A total of 569 displaced people from Syria with depression (PHQ-9 ≥ 10) and impaired functioning (WHODAS > 16) were randomized to Step-by-Step (N = 283; lost to follow-up: N = 167) or ECAU (N = 286; lost to follow-up: 133). Participants were considered to be lost to follow-up when they did not fill in the outcome measures at posttest or follow-up. Recruitment started on December 9, 2019 and was completed on July 9, 2020. The last follow-up assessments were collected in December 2020. The study team had access to the online platform, where they could see treatment arm assignment for each participant. All questionnaires were completed by participants online. Intention-to-treat (ITT) analyses showed intervention effects on depression (standardized mean differences [SMDs]: 0.48; 95% CI: 0.26; 0.70; p < 0.001), impaired functioning (SMD: 0.35; 95% CI: 0.14; 0.56; p < 0.001), post-traumatic stress (SMD: 0.36; 95% CI: 0.16; 0.56; p < 0.001), anxiety (SMD: 0.46; 95% CI: 0.24; 0.68; p < 0.001), subjective well-being (SMD: 0.47; 95% CI: 0.26; 0.68; p < 0.001), and self-identified personal problems (SMD: 0.49; 95% CI 0.28; 0.70; p < 0.001). Significant effects on all outcomes were maintained at 3 months follow-up. During the trial, one serious adverse event occurred, unrelated to the intervention. The main limitation of the current trial is the high dropout rate.
Conclusions: In this study, we found that a guided, digital intervention was effective in reducing depression in displaced people in Lebanon. The guided WHO Step-by-Step intervention we examined should be made available to communities of displaced people that have digital access.
Trial Registration: ClinicalTrials.gov NCT03720769.
Competing Interests: The authors have declared that no competing interests exist.

Erratum in: PLoS Med. 2023 Apr 14;20(4):e1004231. (PMID: 37058690)

Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
Front Psychiatry. 2020 Feb 12;10:986. (PMID: 32116815)
Lancet. 2020 Oct 31;396(10260):1380-1382. (PMID: 32919521)
BMC Med. 2014 Nov 24;12:228. (PMID: 25420518)
Int J Methods Psychiatr Res. 2003;12(2):85-91. (PMID: 12830302)
World Psychiatry. 2018 Feb;17(1):90-101. (PMID: 29352530)
Front Psychiatry. 2019 Jan 25;9:663. (PMID: 30740065)
PLoS One. 2020 Jul 6;15(7):e0234349. (PMID: 32628678)
World Psychiatry. 2019 Oct;18(3):325-336. (PMID: 31496095)
JMIR Res Protoc. 2021 Jan 28;10(1):e21585. (PMID: 33507158)
JAMA Psychiatry. 2019 Jul 1;76(7):700-707. (PMID: 30994877)
Lancet. 2019 Jul 20;394(10194):240-248. (PMID: 31200992)
BMC Public Health. 2021 Jan 26;21(1):217. (PMID: 33499834)
PLoS One. 2014 Jul 16;9(7):e100674. (PMID: 25029507)
Mhealth. 2018 Aug 13;4:34. (PMID: 30225240)
Soc Psychiatry Psychiatr Epidemiol. 2021 Mar;56(3):475-484. (PMID: 32789561)
J Anxiety Disord. 2018 Apr;55:70-78. (PMID: 29422409)
World Psychiatry. 2020 Jun;19(2):251-252. (PMID: 32394577)
Psychiatry Res. 2016 May 30;239:245-52. (PMID: 27031595)
Evid Based Ment Health. 2022 May 16;:. (PMID: 35577536)
N Engl J Med. 1988 Jun 30;318(26):1728-33. (PMID: 3374545)
J Affect Disord. 2017 Dec 1;223:28-40. (PMID: 28715726)
Psychiatry Res. 2016 May 30;239:124-30. (PMID: 27137973)
Br J Psychiatry. 2017 Feb;210(2):119-124. (PMID: 27908899)
Eval Program Plann. 1979;2(3):197-207. (PMID: 10245370)
Front Psychiatry. 2018 Aug 28;9:393. (PMID: 30210373)
Internet Interv. 2021 Mar 04;24:100380. (PMID: 33747798)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
Glob Ment Health (Camb). 2018 Nov 27;5:e39. (PMID: 30637112)
BMC Med. 2018 Mar 13;16(1):40. (PMID: 29530041)

001 International WHO_ World Health Organization

ClinicalTrials.gov NCT03720769

Date Created: 20220623 Date Completed: 20220627 Latest Revision: 20230414

20231215

PMC9223343

10.1371/journal.pmed.1004025

35737665